Conditioning Conditioner

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Cosmetic washes, gels, and emulsions use glycerin in a polyol-humectant role; the listed level is for formulation development.

3. Typical use levels (formulation guide)

• Gels and serums may use the guide range 3–8% in this reference.
• Creams may use the guide range 2–5% as a formulation guide.
• 2–4% is listed for rinse-off.

Add Glycerin to the water phase; no separate melt step is needed.

4. Regulatory sources & global compliance

• Treat any CosIng entry for Glycerin as a reference only; verify the grade and intended use under current market rules.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Glycerin for the completed formula, not simply for an ingredient in isolation.
• For Glycerin, check the purchased grade against its supplier TDS and review filing requirements in the destination market.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; it does not authorize a drug or OTC product and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; if oxidation risk calls for it, review a pump or airless format; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Glycerin emphasizes humectant function.

• The available ingredient details does not demonstrate therapeutic results, cure claims, or unverified certification claims.
• This cosmetic entry naming Glycerin offers no support for whitening, treatment of acne, perspiration control, sun protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

This reference identifies squalane as a stable hydrocarbon emollient and calls for a plant-derived grade, not mineral oil.

3. Typical use levels (formulation guide)

• Formulation guidance for gel-creams: 2–6%.
• The dry oils use-level reference is 10–30%.
• For balms, the reference gives 5–15%.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Regulatory sources & global compliance

• CosIng provides reference information for Squalane; confirm the specific grade and intended use against market requirements.
• For cosmetics placed on the EU market, Regulation (EC) No 1223/2009 requires a safety assessment of the complete cosmetic formula containing Squalane for the product in its final form.
• Use current supplier documentation for the purchased Squalane grade and verify applicable destination-market filings.

5. Safety & risk assessment

The percentage is shown for cosmetic development; it makes no claim of drug or OTC authorization and the completed formula still requires stability and patch testing.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; where oxidation is a concern, evaluate airless or pump packaging; confirm final stability and pack compatibility on a representative batch.

7. Claims language (Do / Don’t)

• The formulation note describes Squalane as part of a cosmetic direction focused on a light-emollient role.

• The ingredient guidance does not demonstrate medical outcomes, cure language, or a product certification not supported by the available facts.
• The ingredient record for Squalane does not establish skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

Shea butter is included as a triglyceride butter for cushioning creams, balms, and hair creams; unrefined color and fragrance are not assumed.

3. Typical use levels (formulation guide)

• Creams may use the guide range 2–8%.
• Formulation guidance for balms and butters: 10–25% for the formula.

Melt the butter into oil and apply shear during cooling so Butyrospermum Parkii Butter does not grain.

4. Regulatory sources & global compliance

• CosIng may identify Butyrospermum Parkii Butter as an ingredient, but its entry does not approve a material grade or finished formula.
• The finished-product provisions of Regulation (EC) No 1223/2009 require a safety assessment covering the complete formulation with Butyrospermum Parkii Butter at the level of the finished cosmetic product.
• Review the documentation for the actual Butyrospermum Parkii Butter grade and the filing requirements for the target market.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it should not be read as a drug authorization or OTC listing and the completed formula still requires stability and patch testing.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; consider an airless or pump format when oxidation sensitivity warrants it; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The cosmetic role of Butyrospermum Parkii Butter is presented as shea cushion.

• The available ingredient details provides no basis for medical outcomes, cure language, or a product certification not supported by the available facts.
• The ingredient record for Butyrospermum Parkii Butter cannot verify whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.